| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701715 | Journal of Thoracic Oncology | 2017 | 25 Pages |
Abstract
Tumor mutational status along with a microRNA-based liquid biopsy can provide additional information in planning clinical follow-up in lung cancer LDCT screening programs.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Carla MSc, Cristina MSc, Todd ScD, Matteo PhD, Andrea MSc, Katherine PhD, Stefano MD, Paola MSc, Elisa PhD, Gabriella PhD, Ugo MD, Mattia PhD,